Kazia Therapeutics (KZIA) Profit After Tax (2009 - 2017)
Kazia Therapeutics (KZIA) posted Profit After Tax of -$8.0 million for Q2 2017, up 12.09% on a QoQ basis from -$9.1 million in Q4 2016, and up 11.69% year-over-year from -$7.2 million in Q2 2016.
Kazia Therapeutics (KZIA) Profit After Tax (2009 - 2017) Analysis & Trends
Kazia Therapeutics' Profit After Tax history runs 9 years deep, the most recent figure standing at -$8.0 million for Q2 2017.
- Quarterly Profit After Tax rose 11.69% year-over-year to -$8.0 million in Q2 2017, while the trailing twelve-month figure through Jun 2017 was -$31.5 million (up 100.0% YoY) and the FY2025 annual result came in at -$13.3 million, up 24.88% from the prior year.
- Profit After Tax was -$8.0 million for Q2 2017 at Kazia Therapeutics, up from -$9.1 million in the prior quarter.
- Across five years, Profit After Tax topped out at -$5.3 million in Q4 2015 and bottomed at -$3069.9 billion in Q4 2013.
- A 5-year average of -$511.7 billion and a median of -$8.5 million in 2016 frame the typical range for Profit After Tax.
- Annual changes were most pronounced in 2013 — Profit After Tax slumped 219010815.42% — and 2014, when it jumped 100.0%.
- Kazia Therapeutics' Profit After Tax stood at -$3069.9 billion in 2013, then soared by 100.0% to -$6.5 million in 2014, then increased by 18.79% to -$5.3 million in 2015, then plunged by 73.41% to -$9.1 million in 2016, then advanced by 12.09% to -$8.0 million in 2017.
- Business Quant data shows KZIA's Profit After Tax at -$8.0 million in Q2 2017, -$9.1 million in Q4 2016, and -$9.1 million in Q2 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -36.84 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -14.46 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 227.36 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -65.60 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 498.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -453.82 Mn |
| 10 | Kazia Therapeutics | 19.25 Bn | 19.25 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2017 | -8.02 Mn |
| Dec 31, 2016 | -9.12 Mn |
| Jun 30, 2016 | -9.08 Mn |
| Dec 31, 2015 | -5.26 Mn |
| Dec 31, 2014 | -6.47 Mn |
| Dec 31, 2013 | -3,069.90 Bn |
| Dec 31, 2012 | -1.40 Mn |
| Oct 8, 2012 | -11.38 Mn |
| Dec 31, 2011 | -932,188.32 |
| Dec 31, 2010 | -5.15 Mn |
| Dec 31, 2009 | -21.62 Mn |